Revalia Bio

🔒 Expanding New Haven biotech Revalia Bio uses donated human organs to test drugs

Revalia Bio plans to expand its New Haven workforce as pharma demand grows for human-organ testing and its technology advances.

Yale bioscience spinout Revalia Bio names Eli Lilly exec CEO

Yale spinout Revalia Bio names Casimir Starsiak III CEO as co-founder Greg Tietjen moves to chief innovation officer.
ADVERTISEMENT

Latest Stories

More Business News

Thought Leadership

More Thought Leadership
ADVERTISEMENT

Movers & Shakers

More Movers & Shakers | Submit Movers & Shakers

Business Announcements

More Announcements | Submit Business Announcements
More Events | Submit an Event